Issued Patents All Time
Showing 1–6 of 6 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 6379901 | Method for screening for cancer using binders for MAGE related peptides and complexes of the peptide and HLA molecules | Thierry Boon-Falleur, Pierre van der Bruggen, Etienne De Plaen, Christophe Lurguin, Catia Traversari +1 more | 2002-04-30 |
| 6222012 | Isolated nonapeptides presented by HLA molecules, and uses thereof | Thierry Boon-Falleur, Pierre van der Bruggen, Etienne De Plaen, Christoph Lurquin, Catia Traversari +2 more | 2001-04-24 |
| 5939526 | Isolated RAGE-1 derived peptides which complex with HLA-B7 molecules and uses thereof | Benoit Van den Eynde, Peter Schrier, Nathalie Brouwenstijn, Thierry Boon-Falleur | 1999-08-17 |
| 5695994 | Isolated cytolytic T cells specific for complexes of MAGE related peptides and HLA molecules | Thierry Boon-Falleur, Pierre van der Bruggen, Etienne De Plaen, Christophe Lurguin, Catia Traversari +1 more | 1997-12-09 |
| 5512437 | Method for determining head and neck squamous cell carcinomas, prostate carcinomas, and bladder tumors by assaying for mage-3 | Thierry Boon-Falleur, Benoit Van den Eynde, Etienne DePlaen, Francis Basseur, Bernard Lethe +1 more | 1996-04-30 |
| 5462871 | Isolated nucleic acid molecules which encode MAGE derived nonapeptides | Thierry Boon-Falleur, Pierre van der Bruggen, Etienne De Plaen, Christophe Lurquin, Catia Traversari +1 more | 1995-10-31 |